<p>The discordant mutations are shown in bold and underlined letters.</p><p>Comparison of drug resistance mutations identified by ViroSeq gentyping system and the in-house assay.</p
<p>Hands - on time and cost comparison between ViroSeq and the in-house HIV-1 genotyping assay.</p
<p>Note: left part based on RT region and right part based on protease region, horizontal numbers in...
<p>Statistically significant p-values (<0.05) are in boldface</p>a<p>Number of patients with resista...
<p>Drug resistance mutations identified in the patient samples sequenced using the Roche/454 GS Juni...
<p>Comparing HIV-1 Drug Resistance Genotyping performance between ATCC and ViroSeq methods with diff...
<p>Pairwise comparisons of the three drug resistance detection techniques (DST, DNA sequencing, and ...
<p>Samples displayed discordant genotypic data between the cell free viruses and the PBMC-viruses ar...
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-n...
<p>Note: horizontal numbers indicate drug resistance mutation sites in RT region with significant di...
Comparison of the number of cases of resistance detection by phenotypic (DST) and genotypic web-base...
<p>Antiviral drug resistance mutations detected in HIV-1 samples from Changchun.</p
Drug resistance mutations and reports obtained by Next-Generation Sequencing.</p
<p>Comparison of the incidences of SMAD4 mutations across different molecular subtypes.</p
Mutations detected in the baseline drug resistance testing (bDRT); global results and results by pat...
a-b & -c: Drug resistance interpretation reports with the resistance of drug mutations between Sange...
<p>Hands - on time and cost comparison between ViroSeq and the in-house HIV-1 genotyping assay.</p
<p>Note: left part based on RT region and right part based on protease region, horizontal numbers in...
<p>Statistically significant p-values (<0.05) are in boldface</p>a<p>Number of patients with resista...
<p>Drug resistance mutations identified in the patient samples sequenced using the Roche/454 GS Juni...
<p>Comparing HIV-1 Drug Resistance Genotyping performance between ATCC and ViroSeq methods with diff...
<p>Pairwise comparisons of the three drug resistance detection techniques (DST, DNA sequencing, and ...
<p>Samples displayed discordant genotypic data between the cell free viruses and the PBMC-viruses ar...
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-n...
<p>Note: horizontal numbers indicate drug resistance mutation sites in RT region with significant di...
Comparison of the number of cases of resistance detection by phenotypic (DST) and genotypic web-base...
<p>Antiviral drug resistance mutations detected in HIV-1 samples from Changchun.</p
Drug resistance mutations and reports obtained by Next-Generation Sequencing.</p
<p>Comparison of the incidences of SMAD4 mutations across different molecular subtypes.</p
Mutations detected in the baseline drug resistance testing (bDRT); global results and results by pat...
a-b & -c: Drug resistance interpretation reports with the resistance of drug mutations between Sange...
<p>Hands - on time and cost comparison between ViroSeq and the in-house HIV-1 genotyping assay.</p
<p>Note: left part based on RT region and right part based on protease region, horizontal numbers in...
<p>Statistically significant p-values (<0.05) are in boldface</p>a<p>Number of patients with resista...
DOI
Add to ORKG